Advocacy at a Glance 2/5/21 Advocacy at a Glance 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More Advocacy at a Glance 1/29/21 Advocacy at a Glance 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More Analysis and Commentary 10/16/20 Analysis and Commentary 10/16/20 Future Changes in Congressional Committees and the FDA Read More Advocacy at a Glance 11/30/18 Advocacy at a Glance 11/30/18 Advocacy at a Glance Read More Advocacy at a Glance 11/9/18 Advocacy at a Glance 11/9/18 Advocacy at a Glance Read More Analysis and Commentary 11/2/18 Analysis and Commentary 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More Analysis and Commentary 10/28/16 Analysis and Commentary 10/28/16 Musical Chairs and Post-Election Congressional Committee Leadership Read More Analysis and Commentary 11/7/14 Analysis and Commentary 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More
Advocacy at a Glance 2/5/21 Advocacy at a Glance 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More
Advocacy at a Glance 1/29/21 Advocacy at a Glance 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More
Analysis and Commentary 10/16/20 Analysis and Commentary 10/16/20 Future Changes in Congressional Committees and the FDA Read More
Analysis and Commentary 11/2/18 Analysis and Commentary 11/2/18 Changes Are Inevitable. Some Predictable; Others Not Read More
Analysis and Commentary 10/28/16 Analysis and Commentary 10/28/16 Musical Chairs and Post-Election Congressional Committee Leadership Read More
Analysis and Commentary 11/7/14 Analysis and Commentary 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More
